Iso-Barrier Available for Hospitals

FARMINGDALE, N.Y.--(BUSINESS WIRE)--Dec. 2, 2004--EnvironmentalRx (EVRX) announced today that the Iso-barrier portable decontamination unit, that recently received a patent, is available to hospitals. The Iso-barrier was designed to control infection by combating bacteria. Today's patients are given antibiotics as part of a standard discharge. This is a result of the extremely high incidents of infections resulting from contamination by other patients. The Iso-barrier will eliminate this need. By using the Iso-barrier between patients, the hospital can completely eliminate the risk of contaminating the next patient. This is consistent with EVRX's goal to step down medication for all patients. EVRX's trained personnel can completely decontaminate a hospital room in 30 minutes. A technician can move the Iso-barrier from room to room as needed. EnvironmentalRx charges $90.00 per bed for this service.

EVRX can have technicians on site full time at the hospital. The technician can move from room to room and decontaminate 16 rooms in an eight-hour shift. This service is available to every hospital in the country. EnvironmentalRx is currently interviewing people to head up this important product. The person selected will coordinate sales and marketing nationwide as well as scheduling.

EnvironmentalRx is a multi faceted company that encompasses health related services, indoor air quality, mold testing and remediation, products and information technology. The company is organized around indoor air quality, pollutant pathways and the methodology to overcome allergic, pathogenic and carcinogenic disease related to microorganisms. Each division is serviced at the EVRX clinics springing up nationwide. Currently operating in Conroe, Texas and Long Island, N.Y.

Except for historical information contained herein, the statements in this release are forward-looking statements that are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the companies' actual results in future periods to differ materially from forecasted results. Such risks and uncertainties include, but are not limited to, market conditions, competitive factors, the ability to successfully complete additional financings and other risks.

BACK TO INVESTOR RELATIONS